Francis Nelson Shen Buys 439,600 Shares of Vitalhub (TSE:VHI) Stock

Vitalhub Corp. (TSE:VHI) Director Francis Nelson Shen acquired 439,600 shares of the stock in a transaction on Tuesday, March 24th. The shares were purchased at an average price of C$7.00 per share, with a total value of C$3,077,200.00. Following the completion of the transaction, the director owned 588,300 shares of the company’s stock, valued at approximately C$4,118,100. This represents a 295.63% increase in their ownership of the stock.

Francis Nelson Shen also recently made the following trade(s):

• On Thursday, March 26th, Francis Nelson Shen acquired 50,000 shares of Vitalhub stock. The stock was acquired at an average cost of C$6.99 per share, for a total transaction of C$349,500.00.

Vitalhub Stock Down 0.4%

Vitalhub stock opened at C$6.95 on Friday. The stock has a market cap of C$439.46 million, a PE ratio of 69.50, a P/E/G ratio of 1.18 and a beta of 0.65. Vitalhub Corp. has a 12-month low of C$6.67 and a 12-month high of C$14.64. The business’s 50-day moving average price is C$8.07 and its two-hundred day moving average price is C$9.30.

Vitalhub (TSE:VHI) last posted its earnings results on Wednesday, March 18th. The company reported C$0.06 EPS for the quarter. The firm had revenue of C$31.39 million during the quarter. Vitalhub had a net margin of 5.61% and a return on equity of 2.75%. As a group, analysts expect that Vitalhub Corp. will post 0.2296467 earnings per share for the current year.

Analysts Set New Price Targets

A number of analysts have weighed in on the stock. ATB Cormark Capital Markets cut their target price on shares of Vitalhub from C$16.50 to C$15.00 and set an “outperform” rating on the stock in a research report on Tuesday, March 10th. Royal Bank Of Canada dropped their price target on Vitalhub from C$13.00 to C$12.00 and set an “outperform” rating for the company in a research note on Monday, January 26th. Raymond James Financial cut their price objective on Vitalhub from C$15.00 to C$11.00 and set an “outperform” rating on the stock in a report on Tuesday, March 24th. Finally, Scotiabank reduced their price objective on Vitalhub from C$15.00 to C$12.00 and set an “outperform” rating on the stock in a research report on Wednesday, February 4th. One analyst has rated the stock with a Strong Buy rating and six have issued a Buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average target price of C$13.86.

About Vitalhub

Vitalhub Corp is Canada-based firm that develops technology solutions for health and human services providers in the mental health (child through adult), long term care, community health service, home health, social service, and acute care sectors. Its technologies include blockchain, mobile, patient flow, web-based assessment, and electronic health record solutions.